Okyo Pharma News and Activities

Okyo Pharma is a company listed under the stock ticker OKYO (GB).

View the org chart displaying its 11 main executives

Most searched biographies at Okyo Pharma

• Robert Dempsey, Chief Executive Officer
• Bernard Denoyer, Non-Executive Director
• Willy Simon, Non-Executive Director

Popular executive movements at Okyo Pharma

• Flavio Mantelli has joined the company as Chief Medical Officer  (posted on February 10 2026).
• Gary Jacob, who was Chief Executive Officer and Director, is promoted to Chief Development Officer and Director  (posted on January 6 2026).
• Robert Dempsey has joined the company as Chief Executive Officer  (posted on January 6 2026).

Create your alert
to follow the executive moves at Okyo Pharma.

Okyo Pharma has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
• Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
• Tissium has just announced a $60 Million fundraising (posted on July 8 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Okyo Pharma

• Media - Okyo Pharma
• Press Releases - Okyo Pharma
• OKYO Pharma
• OKYO Pharma
• OKYO Pharma
• OKYO Pharma
• OKYO Pharma
• OKYO Pharma
• OKYO Pharma
• OKYO Pharma
• View more press releases Close

Social media about Okyo Pharma

• Okyo Pharma on Wikipedia, Google News & Yahoo Finance
• Okyo Pharma on LinkedIn, X (Twitter) & YouTube